Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date

Carmen Criscitiello, Giulia Viale, Giuseppe Curigliano, Aron Goldhirsch European Institute of Oncology, Milano, Italy Abstract: Alteration of the phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian target of rapamycin signaling pathway is key for the growth and survival of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Criscitiello C, Viale G, Curigliano G, Goldhirsch A
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://doaj.org/article/d5bcc36067914069a34e9071aacf3d50
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!